Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells

Immunity

Volumn 33, Issue 2, 2010, Pages 192-202

  Staudt, Valérie ^a   Bothur, Evita ^b   Klein, Matthias ^a   Lingnau, Karen ^c   Reuter, Sebastian ^a   Grebe, Nadine ^a   Gerlitzki, Bastian ^a   Hoffmann, Markus ^a   Ulges, Alexander ^a   Taube, Christian ^a   Dehzad, Nina ^a   Becker, Marc ^a   Stassen, Michael ^a   Steinborn, Andrea ^d   Lohoff, Michael ^b   Schild, Hansjörg ^a   Schmitt, Edgar ^a   Bopp, Tobias ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c INTERCELL AG   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cellimmuno; Molimmuno

Indexed keywords

CYTOKINE ANTIBODY; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; INTERLEUKIN 9; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION; TH9 CELL; UPREGULATION; WILD TYPE;

ANIMALS; ASTHMA; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, SMALL INTERFERING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77955902281     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.07.014     Document Type: Article

References (57)

1. Abrams J.S., Roncarolo M.G., Yssel H., Andersson U., Gleich G.J., Silver J.E. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 1992, 127:5-24.
2. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
3. Behnke J., Wahid F., Grencis R., Else K., Ben-Smith A., Goyal P. Immunological relationships during primary infection with Heligmosomoides polygyrus (Nematospiroides dubius): Downregulation of specific cytokine secretion (IL-9 and IL-10) correlates with poor mastocytosis and chronic survival of adult worms. Parasite Immunol. 1993, 15:415-421.
4. Bopp T., Palmetshofer A., Serfling E., Heib V., Schmitt S., Richter C., Klein M., Schild H., Schmitt E., Stassen M. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J. Exp. Med. 2005, 201:181-187.
5. Brass A.L., Kehrli E., Eisenbeis C.F., Storb U., Singh H. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 1996, 10:2335-2347.
6. Brüstle A., Heink S., Huber M., Rosenplänter C., Stadelmann C., Yu P., Arpaia E., Mak T.W., Kamradt T., Lohoff M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007, 8:958-966.
7. Chang H.C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G.L., Jabeen R., McKinley C., Ahyi A.N., Han L., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 2010, 11:527-534.
8. Cherwinski H., Schumacher J., Brown K., Mosmann T. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 1987, 166:1229-1244.
9. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., Mitsdoerffer M., Strom T.B., Elyaman W., Ho I.C., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 2008, 9:1347-1355.
10. Doull I.J., Lawrence S., Watson M., Begishvili T., Beasley R.W., Lampe F., Holgate T., Morton N.E. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 1996, 153:1280-1284.
11. Gorelik L., Fields P.E., Flavell R.A. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 2000, 165:4773-4777.
12. Gounni A.S., Nutku E., Koussih L., Aris F., Louahed J., Levitt R.C., Nicolaides N.C., Hamid Q. IL-9 expression by human eosinophils: Regulation by IL-1beta and TNF-alpha. J. Allergy Clin. Immunol. 2000, 106:460-466.
13. Gross J., Callas E., Allison J. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992, 149:380-388.
14. Gupta S., Jiang M., Anthony A., Pernis A.B. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 1999, 190:1837-1848.
15. Herrick C.A., Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 2003, 3:405-412.
16. Holgate S.T., Polosa R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 2008, 8:218-230.
17. Holroyd K.J., Martinati L.C., Trabetti E., Scherpbier T., Eleff S.M., Boner A.L., Pignatti P.F., Kiser M.B., Dragwa C.R., Hubbard F., et al. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. Genomics 1998, 52:233-235.
18. Honma K., Kimura D., Tominaga N., Miyakoda M., Matsuyama T., Yui K. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells. Proc. Natl. Acad. Sci. USA 2008, 105:15890-15895.
19. Hu C.M., Jang S.Y., Fanzo J.C., Pernis A.B. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 2002, 277:49238-49246.
20. Huber M., Brustle A., Reinhard K., Guralnik A., Walter G., Mahiny A., von Low E., Lohoff M. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008, 105:20846-20851.
21. Hültner L., Druez C., Moeller J., Uyttenhove C., Schmitt E., Rüde E., Dörmer P., Van Snick J. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur. J. Immunol. 1990, 20:1413-1416.
22. Hültner L., Koelsch S., Stassen M., Kaspers U., Kremer J.P., Mailhammer R., Moeller J., Broszeit H., Schmitt E. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol. 2000, 164:5556-5563.
23. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
24. Khan W.I., Richard M., Akiho H., Blennerhasset P.A., Humphreys N.E., Grencis R., Van Snick J., Collins S.M. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect. Immun. 2003, 71:2430-2438.
25. Kulkarni A.B., Karlsson S. Inflammation and TGF beta 1: Lessons from the TGF beta 1 null mouse. Res. Immunol. 1997, 148:453-456.
26. Kurata H., Lee H.J., O'Garra A., Arai N. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999, 11:677-688.
27. Leech M.D., Grencis R. Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells. J. Immunol. 2006, 176:2505-2511.
28. Leo O., Foo M., Sachs D., Samelson L., Bluestone J. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 1987, 84:1374-1378.
29. Lohoff M., Mak T.W. Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 2005, 5:125-135.
30. Lohoff M., Mittrücker H.W., Prechtl S., Bischof S., Sommer F., Kock S., Ferrick D.A., Duncan G.S., Gessner A., Mak T.W. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 2002, 99:11808-11812.
31. Mittrücker H.W., Matsuyama T., Grossman A., Kündig T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S., Mak T.W. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997, 275:540-543.
32. Monteyne P., Renauld J.C., Van Broeck J., Dunne D.W., Brombacher F., Coutelier J.P. IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 1997, 159:2616-2623.
33. Murphy K., Heimberger A., Loh D. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990, 250:1720-1723.
34. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T., Honda K. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 2005, 102:15989-15994.
35. Nicolaides N.C., Holroyd K.J., Ewart S.L., Eleff S.M., Kiser M.B., Dragwa C.R., Sullivan C.D., Grasso L., Zhang L.Y., Messler C.J., et al. Interleukin 9: A candidate gene for asthma. Proc. Natl. Acad. Sci. USA 1997, 94:13175-13180.
36. Noguchi E., Shibasaki M., Arinami T., Takeda K., Maki T., Miyamoto T., Kawashima T., Kobayashi K., Hamaguchi H. Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population. Am. J. Respir. Crit. Care Med. 1997, 156:1390-1393.
37. Ohara J., Paul W. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 1985, 315:333-336.
38. Pernis A.B. The role of IRF-4 in B and T cell activation and differentiation. J. Interferon Cytokine Res. 2002, 22:111-120.
39. Pongubala J., Nagulapalli S., Klemsz M., McKercher S., Maki R., Atchison M. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol. Cell. Biol. 1992, 12:368-378.
40. Postma D.S., Bleecker E.R., Amelung P.J., Holroyd K.J., Xu J., Panhuysen C.I., Meyers D.A., Levitt R.C. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med. 1995, 333:894-900.
41. Rengarajan J., Mowen K.A., McBride K.D., Smith E.D., Singh H., Glimcher L.H. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 2002, 195:1003-1012.
42. Reuter S., Heinz A., Sieren M., Wiewrodt R., Gelfand E., Stassen M., Buhl R., Taube C. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur. Respir. J. 2007, 31:773-782.
43. Richard M., Grencis R., Humphreys N.E., Renauld J.C., Van Snick J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 2000, 97:767-772.
44. Schmitt E., Van Brandwijk R., Van Snick J., Siebold B., Rüde E. TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur. J. Immunol. 1989, 19:2167-2170.
45. Schmitt E., Germann T., Goedert S., Hoehn P., Huels C., Koelsch S., Kühn R., Müller W., Palm N., Rüde E. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 1994, 153:3989-3996.
46. Schmitt E., Hoehn P., Huels C., Goedert S., Palm N., Rüde E., Germann T. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 1994, 24:793-798.
47. Seder R.A., Paul W. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994, 12:635-673.
48. Stassen M., Klein M., Becker M., Bopp T., Neudorfl C., Richter C., Heib V., Klein-Hessling S., Serfling E., Schild H., Schmitt E. p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. Mol. Immunol. 2007, 44:926-933.
49. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 2007, 19:281-286.
50. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
51. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signalling. Nature 1996, 380:627-630.
52. Temann U.A., Geba G.P., Rankin J.A., Flavell R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 1998, 188:1307-1320.
53. Tominaga N., Ohkusu-Tsukada K., Udono H., Abe R., Matsuyama T., Yui K. Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int. Immunol. 2003, 15:1-10.
54. Veldhoen M., Uyttenhove C., Van Snick J., Helmby H., Westerndorf A., Buer J., Martin B., Wilhelm C., Stockinger B. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
55. Wahl S.M., Chen W. TGF-beta: How tolerant can it be?. Immunol. Res. 2003, 28:167-179.
56. Yamagata T., Nishida J., Tanaka S., Sakai R., Mitani K., Yoshida M., Taniguchi T., Yazaki Y., Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 1996, 16:1283-1294.
57. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.